Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 262 for infectious diseases

Edit search filters
  1. Analytic Treatment Interruption (ATI) to Assess HIV Cure

    Rochester, MN

  2. A Study To Compare The Effectiveness And Safety Of ABT-493/ABT-530 To Sofosbuvir Given Together With Declatasvir In Adults With A Chronic Hepatitis C Virus Infection

    Scottsdale/Phoenix, AZ

  3. A Study to Better Understand the Immune Response to the Flu Vaccine (MF59) and the High Dose Flu Vaccine (HDFlu) in People 65 Years of Age and Older

    Rochester, MN

  4. A Study To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Co-Administration Of ABT-493 And ABT-530 With And Without RBV In Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 Or 6 Infection

    Scottsdale/Phoenix, AZ

  5. Efficacy And Safety Of Maribavir In Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory Or Resistant To Treatment

    Rochester, MN

  6. Will Making the HPV Vaccine Available at Mayo Clinic Express Care with Use of Electronic Point of Care Reminder Improve Overall Vaccination Rates Among an Empaneled Adolescent Population?

    Rochester, MN

  7. Use Of F-652 In Patients With Alcoholic Hepatitis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Mankato, MN, Rochester, MN

  8. An Open Label Study To Examine The Effects Of DAS181 Administered By Dry Powder Inhaler (DPI) Or Nebulized Formulation In Immunocompromised Subjects With Parainfluenza (PIV) Infection

    Scottsdale/Phoenix, AZ

  9. An Expanded Access Study Of Sofosbuvir Combined With Ribavirin And Either With Or Without Pegylated Interferon For Treating Aggressive Post-Transplant Hepatitis C

    Jacksonville, FL

  10. Presatovir In Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection Of The Lower Respiratory Tract

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer